CIK 0001104506
INSM INSMED Inc
Insider trading from SEC Form 4. Last filing Dec 20, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at INSMED Inc, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 15Weak | sell10b5-1 | Lewis William Chair and CEO | $1.8M | 25,580 | -6% | - | |
| 15Weak | sell10b5-1 | Lewis William Chair and CEO | $1.9M | 25,580 | -6% | - |
Congressional trades
7 trades in INSM disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Josh Gottheimer House · D-NJ | Partial sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Jun 10, 2026 | 27 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Oct 3, 2025 | 46 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Sep 22, 2025 | 18 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Aug 8, 2025 | 35 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Jul 7, 2025 | 38 days after the trade |
| Josh Gottheimer House · D-NJ | Purchase | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Jun 16, 2025 | 30 days after the trade |
| Josh Gottheimer House · D-NJ | Partial sale | INSM Insmed Incorporated - Common Stock | $1,001 to $15k | Apr 9, 2025 | 35 days after the trade |
Transactions
The last 18 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Lewis William Chair and CEO | MOption exercise Common Stock10b5-1 | +18,750 | $22.76 | $427k | 403,710 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stock10b5-1 | -13,162 | $69.65 | $917k | 390,548 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stock10b5-1 | -5,588 | $70.52 | $394k | 384,960 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | MOption exercise Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | +6,830 | $10.85 | $74k | 240,754 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | -5,240 | $69.71 | $365k | 235,514 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | -1,590 | $70.61 | $112k | 233,924 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -18,750 | $0.00 | $0 | 112,500 | Dec 20, 2024 |
| Dec 19, 2024 | Lewis William Chair and CEO | MOption exercise Stock Option (right to buy)derivativeindirect: By the Katie Procter Dynasty Trust10b5-1 | -6,830 | $0.00 | $0 | 232,290 | Dec 20, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | MOption exercise Common Stock10b5-1 | +18,750 | $22.76 | $427k | 403,710 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stock10b5-1 | -11,504 | $72.58 | $835k | 392,206 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stock10b5-1 | -6,847 | $73.56 | $504k | 385,359 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stock10b5-1 | -399 | $74.23 | $30k | 384,960 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | MOption exercise Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | +6,830 | $10.85 | $74k | 240,754 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | -4,087 | $72.57 | $297k | 236,667 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | -2,562 | $73.55 | $188k | 234,105 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | SOpen-market sale Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1 | -181 | $74.22 | $13k | 233,924 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -18,750 | $0.00 | $0 | 131,250 | Dec 13, 2024 |
| Dec 12, 2024 | Lewis William Chair and CEO | MOption exercise Stock Option (right to buy)derivativeindirect: By the Katie Procter Dynasty Trust10b5-1 | -6,830 | $0.00 | $0 | 239,120 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.